1.
Renin–Angiotensin–Aldosterone System Inhibitors in COVID-19: A Review. Clinics [Internet]. 2021 Nov. 9 [cited 2024 May 8];76:e2342. Available from: https://www.revistas.usp.br/clinics/article/view/191929